Purpose
The present study investigated the psychosocial health of disease-free breast cancer survivors who receive health examinations compared to matched non-cancer controls in a community setting.
Materials and Methods
We used baseline data from the Health Examinee cohort, which is composed of subjects participating in health. The disease-free breast cancer survivors were defined as those who were ≥ 2 years from initial diagnosis of breast cancer who had completed treatment. Females without a history of cancer were randomly selected at 1:4 ratio by 5-year age groups, education, and household income as a comparison group. We analyzed results from the Psychosocial Well-being Index-Short Form (PWI-SF) as a psychosocial health measurement.
Results
A total of 347 survivors of breast cancer and 1,388 matched controls were included. Total scores on the PWI-SF were lower in breast cancer survivors than matched non-cancer controls (p=0.006), suggesting a lower level of psychosocial stress in breast cancer survivors. In comparison to the control group, prevalence of drinking, smoking and obesity were lower, while exercising for ≥ 150 min/wk was higher in breast cancer survivors (p < 0.05). These findings suggest that breast cancer survivors have better health behaviors than their noncancer controls. After adjusting for other sociodemographic variables, breast cancer survivors were 36% less likely to be included in the stress group (odds ratio, 0.64; 95% confidence interval, 0.42 to 0.98).
Conclusion
The disease-free breast cancer survivors resuming daily life demonstrated better psychosocial health status compared to matched non-cancer controls.
Citations
Citations to this article as recorded by
Effect of perceived injustice-targeted pain neuroscience education compared with biomedically focused education in breast cancer survivors: a study protocol for a multicentre randomised controlled trial (BCS-PI trial) Eva Roose, Eva Huysmans, Laurence Leysen, Kenza Mostaqim, Paul Van Wilgen, David Beckwée, Marijke De Couck, Annick Timmermans, Rinske Bults, Jo Nijs, Astrid Lahousse BMJ Open.2024; 14(1): e075779. CrossRef
Effects of a Single Session of Mindfulness and Compassion on Skin Temperature in Breast Cancer Survivors David A. Rodríguez, Nadia Martínez, Li Erandi Tepepa Flores, Benjamín Domínguez, Patricia Cortés, Ana L. Chávez International Journal of Environmental Research and Public Health.2024; 21(8): 1064. CrossRef
Gender Difference in the Impact of Total Energy Intake on the Association between Low Fiber Intake and Mental Health in Middle-Aged and Older Adults Sinyoung Cho, Minseon Park Nutrients.2024; 16(16): 2583. CrossRef
Psychological factors influencing healthcare utilization in breast cancer survivors with pain Eva Roose, Wilfried Cools, Laurence Leysen, Paul Van Wilgen, David Beckwée, Annick Timmermans, Rinske Bults, Jo Nijs, Marian Vanhoeij, Christel Fontaine, Astrid Lahousse, Eva Huysmans Pain Medicine.2024; 25(12): 768. CrossRef
Determinants of Psychosocial Distress in Breast Cancer Patients at a Safety Net Hospital Jessica K. Liu, Amy H. Kaji, Katherine G. Roth, Danielle M. Hari, James J. Yeh, Christine Dauphine, Junko Ozao-Choy, Kathryn T. Chen Clinical Breast Cancer.2022; 22(1): 43. CrossRef
Self-Concept and Psychosocial Well-Being among Korean Women with BRCA1/2 Gene Mutations Kyunghwa Lee, Doo Ree Kim Asian Oncology Nursing.2022; 22(1): 11. CrossRef
Psychosocial stress accompanied by an unhealthy eating behavior is associated with abdominal obesity in Korean adults: A community-based prospective cohort study Minji Kim, Yangha Kim Frontiers in Nutrition.2022;[Epub] CrossRef
Effect of Psychosocial Distress on the Rate of Kidney Function Decline Jae Young Kim, Young Su Joo, Jong Hyun Jhee, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Jung Tak Park Journal of General Internal Medicine.2021; 36(10): 2966. CrossRef
Signifikanter Überlebensvorteil durch Sacituzumab-Govitecan beim TNBC Sebastian Weiße, Svenja Quaester, Jürgen Dunst InFo Hämatologie + Onkologie.2021; 24(9): 29. CrossRef
Purpose
We evaluated health-related quality of life (HRQOL) in long-term survivors of indolent and aggressive non-Hodgkin lymphoma (NHL).
Materials and Methods
TheHRQOLwas assessed by the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 (EORTC QLQ-C30) at diagnosis in NHL patients between 2008 and 2011, and follow-up evaluation was conducted from June 2014 to February 2015 using EORTC QLQ-C30 and the quality of life in cancer survivors (QOL-CS) questionnaire. We used linear mixed models to compare changes in HRQOL between indolent and aggressive NHL over time.
Results
The HRQOL of long-term survivors with aggressive NHL improved to the similar level of indolent NHL during the follow-up survey. However, survivors of NHL were found to fear the probability of relapse and second malignancy, and the degree of fear was not different between survivors with aggressive stage I/II or III/IV NHL (p > 0.05). Furthermore, a half of survivors reported impaired sense of psychosocial well-being regardless of aggressiveness and stage during follow-up survey. More than 65% of survivors thought they did not receive sufficient support from others, and patients who had financial difficulties at diagnosis were more frequently associated with suffering from insufficient support. Impaired physical and cognitive functioning at diagnosis was significantly associated with lack of life purpose in long-term survivors.
Conclusion
The HRQOL of aggressive NHL survivors improved to a similar level to that of indolent NHL. However, the majority of survivors still had fear of relapse, and psychosocial well-being remained unmet needs.
Citations
Citations to this article as recorded by
Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study Meghavi Kathpalia, Pinki Mishra, Afsha Majid, Mohd. Ashif Khan, Anurag Sharma, Dinesh Bhurani, Nidhi Journal of Neuroimmunology.2024; 392: 578372. CrossRef
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study Azza Ayad, Reham Khedr, Asmaa Hamoda, Nahla Elnabarawy, Elhamy Rifky, Tamer Diab, Eman El Desouky, Leslie Lehmann, Alaa Elhaddad Pediatric Blood & Cancer.2024;[Epub] CrossRef
Willingness to pay per quality-adjusted life year of Non-Hodgkin Lymphoma patients in Vietnam Phan Gia Huy, Pham Xuan Dung, Dang The Thap, Nguyen Tran Nhu Y Tạp Chí Khoa học Trường Đại học Quốc tế Hồng Bàng.2024; : 11. CrossRef
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study Sohee Park, Ju Hwan Kim, Songhee Kim, Jisu Kang, Seoyoung Moon, Seok Jin Kim, Ju-Young Shin Blood Cancer Journal.2023;[Epub] CrossRef
Factors associated with long-term functional and psychosocial outcomes in patients with non-Hodgkin lymphoma Bhasker Amatya, Michael Dickinson , Fary Khan Journal of Rehabilitation Medicine.2023; 55: jrm004816. CrossRef
Experiences of and preferences for self-management among low grade non-Hodgkin's lymphoma survivors: A qualitative interview study Nickola D. Pallin, Mairead O'Connor, Alannah Gannon, John Browne, Mary R. Cahill, Derville O'Shea European Journal of Oncology Nursing.2023; 66: 102378. CrossRef
Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study Stephane Kroudia Wasse, Morgane Mounier, Emerline Assogba, Cédric Rossi, Johan Adnet, Sophie Gauthier, Stephanie Girard, Kueshivi Midodji Atsou, Tienhan Sandrine Dabakuyo-Yonli, Marc Maynadie Cancers.2023; 15(15): 3885. CrossRef
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study Leo I. Gordon, Fei Fei Liu, Julia Braverman, Daanish Hoda, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C. Hildebrandt, Lily Peng, Shien Guo, Ling Shi, Alison Sehgal Haematologica.2023; 109(3): 857. CrossRef
Quality of life and fear of cancer recurrence in patients and survivors of non-Hodgkin lymphoma Susan Ellis, Rhonda F. Brown, Einar B. Thorsteinsson, Kenneth I. Pakenham, Colin Perrott Psychology, Health & Medicine.2022; 27(8): 1649. CrossRef
Pre‐treatment health‐related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience Åsa Lindberg, Christian Winther Eskelund, Alexandra Albertsson‐Lindblad, Arne Kolstad, Anna Laurell, Riikka Räty, Kirsten Grønbæk, Christian Hartmann Geisler, Mats Jerkeman Hematological Oncology.2022; 40(1): 23. CrossRef
Treatment Outcomes and Its Associated Factors Among Adult Patients with Selected Solid Malignancies at Kenyatta National Hospital: A Hospital-Based Prospective Cohort Study Amsalu Degu, Ermias Mergia Terefe, Eliab Seroney Some, Gobezie T Tegegne Cancer Management and Research.2022; Volume 14: 1525. CrossRef
Living with or beyond lymphoma: A rapid review of the unmet needs of lymphoma survivors Vanessa Boland, Amanda Drury, Greg Sheaf, Anne‐Marie Brady Psycho-Oncology.2022; 31(7): 1076. CrossRef
The forgotten survivor: A comprehensive review on Non‐Hodgkin lymphoma survivorship Mohamad S. Alabdaljabar, Urshila Durani, Carrie A. Thompson, Louis S. Constine, Shahrukh K. Hashmi American Journal of Hematology.2022; 97(12): 1627. CrossRef
Unmet Needs and Quality of Life of Colorectal Cancer Survivors Immediately after Treatment Ends and 5 Years Hyedan Kim, Eunsook Wi, Mi Hwa Jang, Sung Hee Jo, Hye Kyung Kim Asian Oncology Nursing.2022; 22(3): 145. CrossRef
Trajectories of symptom severity predicts quality of life change in newly diagnosis lymphoma survivors: An initial study Chih‐Jung Wu, Yu‐Chi Chen, Li‐Yuan Bai, Tzeon‐Jye Chiou, Kuan‐Chia Lin, Ya‐Jung Wang European Journal of Cancer Care.2022;[Epub] CrossRef
Exploring health-related quality of life among non-Hodgkin’s lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand Pichitra Lekdamrongkul, Kanaungnit Pongthavornkamol, Alex Molassiotis, Aurawamon Sriyuktasuth, Noppadol Siritanaratkul, Natkamol Chansatitporn Supportive Care in Cancer.2021; 29(11): 6511. CrossRef
Experiences of patients with lung cancer receiving concurrent chemo-radiotherapy Choi Eunsook, Park Sunhee Clinical Journal of Nursing Care and Practice.2021; 5(1): 015. CrossRef
Coping strategies among patients with malignant lymphoma– a qualitative study from the perspectives of Swedish patients Stinne Glasdam, Charlotta Bjerström, Cecilia Engberg de Carvalho European Journal of Oncology Nursing.2020; 44: 101693. CrossRef
Impact of fear of cancer recurrence on survival among lymphoma patients Seok Jin Kim, Danbee Kang, Im Ryung Kim, Sang Eun Yoon, Won Seog Kim, Phyllis N. Butow, Eliseo Guallar, Juhee Cho Psycho-Oncology.2020; 29(2): 364. CrossRef
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphoma Andrew Davies, Peter Trask, Judit Demeter, Axel Florschütz, Mathias Hänel, Tomohiro Kinoshita, Ruth Pettengell, Hang Quach, Stephen Robinson, Shalal Sadullah, Juan-Manuel Sancho, Miklos Udvardy, Mathias Witzens-Harig, Andrea Knapp, Wenxin Liu Annals of Hematology.2020; 99(12): 2837. CrossRef
Quality of Life and Impact of Cancer: Differences in Rural and Nonrural Non‐Hodgkin's Lymphoma Survivors Devon Noonan, Matthew LeBlanc, Cherie Conley, Habtamu Benecha, Ashley Leak‐Bryant, Kellen Peter, Sheryl Zimmerman, Deborah Mayer, Sophia Smith The Journal of Rural Health.2020; 36(4): 536. CrossRef
Semen quality in non-Hodgkin lymphoma survivors: a monocentric retrospective study Francesco Pallotti, Marianna Pelloni, Fabiana Faja, Silvia Di Chiano, Alice Di Rocco, Andrea Lenzi, Francesco Lombardo, Donatella Paoli Human Reproduction.2020;[Epub] CrossRef
Prognostic Value of Post-diagnosis Health-Related Quality of Life for Overall Survival in Breast Cancer: Findings from a 10-Year Prospective Cohort in Korea Tran Thi Xuan Mai, Jin Hyuk Choi, Myung Kyung Lee, Yoon Jung Chang, So-Youn Jung, Hyunsoon Cho, Eun Sook Lee Cancer Research and Treatment.2019; 51(4): 1600. CrossRef